AURINIA PHARMACEUTICALS INC's ticker is and the CUSIP is 05156V952. A total of 3 filers reported holding AURINIA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $8,429,000 | -6.1% | 609,500 | 0.0% | 1.75% | +40.0% |
| Q3 2020 | $8,978,000 | +72.5% | 609,500 | +90.3% | 1.25% | +115.7% |
| Q2 2020 | $5,205,000 | +19.6% | 320,300 | +6.8% | 0.58% | -18.0% |
| Q1 2020 | $4,353,000 | +43.2% | 300,000 | +100.0% | 0.71% | +14.6% |
| Q4 2019 | $3,039,000 | – | 150,000 | – | 0.62% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Maven Securities LTD | 25,000 | $2,324,000 | 0.07% |
| GROUP ONE TRADING, L.P. | 565,200 | $12,926,000 | 0.01% |
| SIMPLEX TRADING, LLC | 173,600 | $3,970,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| JPMORGAN CHASE & CO | 130,700 | $2,989,000 | 0.00% |